Alexandros makriyannis
Recent Patents on CNS Drug Discovery (Discontinued) CD147: A Novel Modulator of Inflammatory and Immune DisordersĬurrent Medicinal Chemistry Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory AgentsĬurrent Medicinal Chemistry Meet Our Editorial Board Member:Ĭurrent Alzheimer Research The Mechanism of Memory Impairment Induced by Aβ Chronic Administration Involves Imbalance between Cytokines and Neurotrophins in the Rat HippocampusĬurrent Alzheimer Research Functional Autoradiography Shows Unaltered Cannabinoid CB1 Receptor Signalling in Hippocampus and Cortex of APP/PS1 Transgenic MiceĬNS & Neurological Disorders - Drug Targets A Novel Prion Protein-Tyrosine Hydroxylase InteractionĬNS & Neurological Disorders - Drug Targets Membrane Lipids in the Function of Serotonin and Adrenergic ReceptorsĬurrent Medicinal Chemistry Patent Annotations
Prior to these appointments, he maintained a highly successful research and. He is also Professor of both Chemistry and Chemical Biology and Pharmaceutical Sciences. Cognitive and Psychomotor Performance During Alcohol HangoverĬurrent Drug Abuse Reviews Alcohol Use in the Greek System, 1999-2009: A Decade of ProgressĬurrent Drug Abuse Reviews Using Simulations to Explore the Characteristics of CT Perfusion Calculations in the Assessment of StrokeĬurrent Medical Imaging Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research DirectionĬNS & Neurological Disorders - Drug Targets Special Issue on Medical Imaging Technologies for IoT Based Wireless Patient MonitoringĬurrent Medical Imaging New Psychoactive Substances: A Matter of TimeĬurrent Neuropharmacology Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders Behrakis Endowed Chair in Pharmaceutical Biotechnology and Director of the Center for Drug Discovery.